Related Experiment Video
Updated: Mar 3, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report
Willy Liu1, Jean Delwaide1, Noella Bletard1
1Willy Liu, Olivier Detry, Department of Abdominal Surgery and Transplantation, CHU Liege (CHU-ULg), B4000 Liege, Belgium.
Abstract:
Positron emission tomography computed tomography (PET-CT) using 18-Fluoro-deoxyglucose (18FDG) is an imaging modality that reflects cellular glucose metabolism. Most cancers show an uptake of 18FDG and benign tumors do not usually behave in such a way. The authors report herein the case of a 38-year-old female patient with a past medical history of cervical intraepithelial neoplasia and pheochromocytoma, in whom a liver lesion had been detected with PET-CT. The tumor was laparoscopically resected and the diagnosis of inflammatory hepatic adenoma was confirmed. This is the first description of an inflammatory hepatic adenoma with an 18FDG up-take.

